
Ruxolitinib (Jakavi)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.478
Subject(s) - reimbursement , ruxolitinib , medicine , family medicine , drug , pharmacology , political science , health care , myelofibrosis , bone marrow , law